Articles related to PATIENT SAFETY

A systematic review of reported vision loss cases following nonsurgical rhinoplasty found that visual impairment was typically immediate and often irreversible despite treatment. The findings highlight a rare but severe complication associated with cosmetic dermal filler injections.

An expert presentation at an obstetric ultrasound congress highlighted how real-time ultrasound guidance may improve the completeness and safety of early pregnancy procedures by maintaining instrument visualization and reducing procedural complications.

Fetal macrosomia showed the strongest association with shoulder dystocia in a single-center case-control study of vaginal deliveries. Maternal overweight and diabetes also contributed to risk, while the low event count and retrospective design limit prediction.

The FDA classified a recall of dorzolamide and timolol ophthalmic solution as a Class II event after reports of defective containers, affecting a specific lot used to treat glaucoma and ocular hypertension.

The FDA classified a recall of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief as a Class II event after the manufacturer identified sterility concerns and potential contamination affecting a single lot.

Testimony from a psychiatrist in the Lindsay Clancy murder trial has highlighted how clinical documentation, incomplete information, and retrospective interpretation of psychiatric records can become central evidence in legal proceedings without resolving underlying questions of diagnosis or criminal responsibility.